Squarepoint
LJPC

Squarepoint’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Squarepoint’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-13,227
Closed -$57K – 3776
2021
Q2 		$57K Sell
13,227
-20,761
-61% -$88.9K ﹤0.01% 3095
2021
Q1 		$144K Buy
+33,988
New +$187K ﹤0.01% 2811
2020
Q4 		– Sell
-12,998
Closed -$52K – 3474
2020
Q3 		$52K Buy
+12,998
New +$53.8K ﹤0.01% 2365
2020
Q1 		– Sell
-31,390
Closed -$123K – 2871
2019
Q4 		$123K Buy
+31,390
New +$185K ﹤0.01% 2314
2019
Q1 		– Sell
-25,117
Closed -$237K – 2630
2018
Q4 		$237K Sell
25,117
-12,485
-33% -$188K ﹤0.01% 1613
2018
Q3 		$757K Buy
37,602
+16,202
+76% +$423K 0.01% 1118
2018
Q2 		$624K Buy
21,400
+9,108
+74% +$281K 0.01% 1089
2018
Q1 		$366K Sell
12,292
-6,528
-35% -$210K 0.01% 1220
2017
Q4 		$606K Buy
+18,820
New +$615K 0.01% 1089
2016
Q2 		– Sell
-14,500
Closed -$303K – 1546
2016
Q1 		$303K Buy
+14,500
New +$259K 0.02% 821

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $310M AUM 37.86% 1-Year Est. Return
KT
Kevin Tang $783 AUM 75.59% 1-Year Est. Return

Squarepoint's LJPC Position: Q3 2021 in Review

Squarepoint sold out of La Jolla Pharmaceutical Company (LJPC) in Q3 2021, closing a stake of 13,227 shares — an estimated $57K sold.

Squarepoint first reported a position in LJPC in Q1 2016 and held it in 10 quarters. The position peaked at $757K in Q3 2018. 54 funds tracked by Wall St. Rank hold LJPC as of Q3 2021.

  • Squarepoint reported no remaining La Jolla Pharmaceutical Company position as of Q3 2021 after selling out during the quarter.
  • Squarepoint sold 13,227 La Jolla Pharmaceutical Company shares in Q3 2021, an estimated $57K.
  • Squarepoint first reported a position in La Jolla Pharmaceutical Company in Q1 2016 and held it in 10 quarters.
  • Squarepoint's La Jolla Pharmaceutical Company position peaked at $757K in Q3 2018.
  • 54 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q3 2021.

Based on Squarepoint's 13F filing for Q3 2021, filed 15 Nov 2021.